Carbamylation of Integrin IIb 3: The Mechanistic Link to Platelet Dysfunction in ESKD

Veronika Binder1, Barbara Chruścicka-Smaga2, Brith Bergum1

  • 1Broegelmann Research Laboratory, University of Bergen, Bergen, Norway.

Insights

Carbamylation, a protein modification linked to uremia, impairs platelet function in patients with end-stage kidney disease (ESKD). Supplementing amino acids may restore platelet activity, improving hemostasis during dialysis.

Area of Science:

  • Nephrology
  • Hematology
  • Biochemistry

Background:

  • Patients with end-stage kidney disease (ESKD) often experience bleeding issues, especially during procedures.
  • Uremia in ESKD elevates cyanate levels, causing carbamylation, an irreversible protein modification.
  • Carbamylation may contribute to platelet dysfunction observed in ESKD patients.

Purpose of the Study:

  • To investigate carbamylation as a mechanistic link between uremia and platelet dysfunction in ESKD.
  • To quantify carbamylation in ESKD patients and assess its effect on platelet function.

Main Methods:

  • HPLC-MS/MS to quantify homocitrulline (a marker of carbamylation).
  • Biotin-conjugated phenylglyoxal labeling and Western blot to detect carbamylated integrin αIIbβ3.
  • Flow cytometry to assess platelet activation, adhesion, and aggregation assays.

Main Results:

  • Carbamylation significantly inhibited platelet activation, adhesion, and aggregation.
  • Platelets from hemodialysis patients showed reduced integrin αIIbβ3 activation and increased carbamylation compared to controls.
  • In vitro, modification of lysine 185 in the β3 subunit impaired receptor activity and fibrinogen binding.

Conclusions:

  • Carbamylation of integrin αIIbβ3, specifically at K185, links uremia to primary hemostasis dysfunction in hemodialysis patients.
  • Free amino acid supplementation prevented carbamylation-induced loss of αIIbβ3 activity, suggesting a therapeutic potential for normalizing platelet function.
Abstract

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
619
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
28